Search Results: regulatory – Page 2

Search
The FDA has provided direction on the use of AI for drug and biologic development. Here’s what life sciences teams should know.
Before we head into the new year, let’s reflect on some of the most significant news stories in health tech from December

Denials management Reduce denials, write-offs, and retrospective coding Stop revenue loss before it starts with proactive upstream and downstream denials management. schedule

Hospitals are losing millions to rising costs and incomplete documentation. Learn how precise terminology can prevent costly denials and protect revenue.
Learn how Norstella automated code updates, reduced onboarding and cleansing time, and decreased manual labor costs by partnering with IMO Health.
The addition of USCDI V3 and V4 to IMO Health’s proprietary lexicon ensures health systems comply with rapidly evolving regulations, avoiding costly
The U.S. government uses the National Drug Code (NDC) to identify and track drugs intended for human use. Get up to speed
Ambient intelligence tools are skilled at recording patient-provider encounters in real-time. But can they truly understand them?
Pharma’s SLR workflows are slow, costly, and error-prone. See how AI and clinical terminology accelerate evidence generation with precision and trust.
See how Cedars-Sinai streamlined lab data exchange and improved reporting accuracy through better LOINC mapping.
IMO Health’s new solution reduces systematic literature review time from months to days without sacrificing accuracy or reproducibility.
IMO Health is growing its life sciences offerings to improve trial efficiency, accelerate evidence generation, and advance patient care.